
Sefraz CV 500mg/125mg Tablet
Marketer
Oddiant Formulations
Salt Composition
Cefuroxime (500mg) + Clavulanic Acid (125mg)
Overview Sefraz CV 500mg/125mg Tablet
Combiflox 500mg/125mg tablets combat various bacterial infections by inhibiting microbial proliferation. This prescription medication should be administered precisely as directed. It may be taken with or without food, but consistent timing maximizes effectiveness. Exceeding the prescribed dosage can be detrimental. Missed doses should be taken promptly upon recollection. Complete the entire course of treatment, even with symptom improvement; premature cessation can reduce efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require urgent medical care. Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration support recovery. Your doctor might order tests to monitor the medication's impact.
Primary Ingredients of Sefraz CV 500mg/125mg Tablet
No text was provided to rewrite.
Uses of Sefraz CV 500mg/125mg Tablet
Managing Bacterial Infections
Major Benefits of Sefraz CV 500mg/125mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Sefraz CV 500mg/125mg Tablets. Swallow each tablet whole; avoid chewing, crushing, or breaking. While this medication can be taken with or without food, consistency is key – take it at the same time each day.
Common Side effects of Sefraz CV 500mg/125mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Increased liver enzymes
- Allergic reaction
How to use Sefraz CV 500mg/125mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the 500mg/125mg Sefraz CV Tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Sefraz CV 500mg/125mg Tablet works:
Each Sefraz CV 500mg/125mg tablet unites Cefuroxime, an antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor. Cefuroxime combats bacterial infection by disrupting the creation of their protective shell, crucial for their viability. Clavulanic Acid counteracts bacterial enzymes that deactivate Cefuroxime, thus broadening Cefuroxime's effectiveness and mitigating bacterial resistance.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Sefraz CV 500mg/125mg Tablet and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The use of Sefraz CV 500mg/125mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactating individuals may safely use Sefraz CV 500mg/125mg tablets. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingNOT RELEVANT
Inapplicable, given that Sefraz CV 500mg/125mg Tablets are designated for inpatient administration.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Sefraz CV 500mg/125mg tablets to individuals with renal impairment. Seek medical advice.
LiverCONSULT YOUR DOCTOR
Data regarding Sefraz CV 500mg/125mg Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Sefraz CV 500mg/125mg Tablet :
Should you forget to take a Sefraz CV 500mg/125mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Sefraz CV 500mg/125mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
